On October 15, one participant died during a vaccine trial at Oxford University and AstraZeneca being developed to control the global pandemic Corona. The case came to light in Sao Paulo, Brazil, where the third phase of the vaccine is being tested. Indeed, a 28-year-old man from Rio-de-Janeiro, who was involved in the trial, suffered health problems after giving his first dose of the vaccine and later died.
The incident has raised doubts about the vaccine. However, the company has refused to stop the trial. According to the World Health Organization, 42 potential corona vaccines are currently being tested, ten of which are in Phase III. Significantly, Brazil has the highest outbreak of Coronavirus after America. More than 1,54,000 people have died in Brazil due to Corona.
Oxford claims, not the vaccine, cause of death.
However, Oxford claims that the participant did not die due to the vaccine during the Phase III trial. Brazilian health authority Avisa has stated that this participant died due to a severe corona condition. he was not administered the vaccine dose during the trial but rather was administered Placevoe, which is not a real drug. Denying any adverse effects of the vaccine, it has recommended continuing the Phase III trial.
Everything is moving as expected.
According to the information, 8,000 out of 10,000 participants were involved in the Phase III trial of the AstraZeneca vaccine released in Brazil. These participants were given vaccine doses in hospitals in six Brazilian cities. The Brazilian University, which is assisting the company in the Phase III trial, claimed that no vaccine-related side effects were observed in any of the participants. Everything is proceeding as expected.
Trial related to AstraZeneca stopped in US.
AstraZeneca’s AZD-1222 test at the forefront of the vaccine race against Corona continues in the US. The US Food and Drug Administration (FDA) had stopped its testing to check for side effects in a patient. However, according to US Health and Human Services Secretary Alex Azar, its Phase III trials are underway in other countries. In this sequence, it was being tested in Brazil, where one participant died. Let me tell you that earlier, Johnson & Johnson Company also stopped the trial of its Corona vaccine. The trial was stopped after a participant fell ill.
Cyberattack on Indian company testing Russian vaccines
Russian vaccine Sputnik-V is being tested in India at ‘Dr. Reddys Laboratories’ facility has also been attacked by the cyberattack. After this, it has stopped the services of all data centers around the world. The company said on Thursday that it did so to take rescue measures after the cyberattack was identified. Dr. Reddy’s has drug plants in the United States, Britain, Brazil, Russia, and India. Recently, Dr. Reddy’s Laboratories was approved for the trial of the Russian Corona Virus Vaccine.